ID

18027

Beskrivning

Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00240565

Länk

https://clinicaltrials.gov/show/NCT00240565

Nyckelord

Versioner (1)
  1. 2016-10-15 2016-10-15 -
Uppladdad den

15 oktober 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Lymphoma, Non-Hodgkin NCT00240565

Engelsk

Eligibility Lymphoma, Non-Hodgkin NCT00240565

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must have evidence of persistent or progressive follicular grade, 1, 2 or 3 or marginal zone b-cell non-hodgkin's lymphoma.
Beskrivning

Lymphoma, Follicular persistent Evidence | Lymphoma, Follicular Progressive Evidence | Ann Arbor lymphoma staging system | Marginal Zone B-Cell Lymphoma Evidence

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C0205322
UMLS CUI [1,3]
C3887511
UMLS CUI [2,1]
C0024301
UMLS CUI [2,2]
C0205329
UMLS CUI [2,3]
C3887511
UMLS CUI [3]
C0432516
UMLS CUI [4,1]
C1367654
UMLS CUI [4,2]
C3887511
must have received at least two prior courses of systemic treatment including at least one treatment of rituximab (lymphoma must not have progressed during their most recent systemic chemotherapy treatment).
Beskrivning

systemic therapy Course Quantity Lymphoma | rituximab | Disease Progression | Systemic Chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0750729
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0024299
UMLS CUI [2]
C0393022
UMLS CUI [3]
C0242656
UMLS CUI [4]
C1883256
must have evidence that their lymphoma expresses cd20 antigen and have adequate renal and hepatic function.
Beskrivning

Lymphoma CD20 Antigen Expression Evidence | Renal function | Liver function

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0054946
UMLS CUI [1,3]
C0017262
UMLS CUI [1,4]
C3887511
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
received chemotherapy, radiation therapy, immunosuppressants or cytokine treatment within 4 weeks prior to study entry.
Beskrivning

Chemotherapy | Therapeutic radiology procedure | Immunosuppressive Agents | Cytokine therapy

Datatyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0021081
UMLS CUI [4]
C0199974
have active obstructive hydronephrosis.
Beskrivning

Hydronephrosis Obstructive

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020295
UMLS CUI [1,2]
C0549186
had prior autologous hematopoietic stem cell transplant or any allogenic stem cell transplant.
Beskrivning

Transplantation of autologous hematopoietic stem cell | Allogeneic Stem Cell Transplantation

Datatyp

boolean

Alias
UMLS CUI [1]
C1831743
UMLS CUI [2]
C2242529
have active infection requiring iv antibiotics.
Beskrivning

Communicable Disease Requirement Intravenous antibiotic therapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0559680
have brain or leptomeningeal metastasis.
Beskrivning

Metastatic malignant neoplasm to brain | Metastatic Malignant Neoplasm to the Leptomeninges

Datatyp

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C1704231
had previous allergic reaction to iodine, previously received radioimmunotherapy or are currently receiving approved or experimental anti-cancer drugs.
Beskrivning

Allergic Reaction Iodine | Radioimmunotherapy | Antineoplastic Agents Approved | Antineoplastic Agents Investigational

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0021968
UMLS CUI [2]
C0085101
UMLS CUI [3,1]
C0003392
UMLS CUI [3,2]
C0205540
UMLS CUI [4,1]
C0003392
UMLS CUI [4,2]
C1517586
patients who are pregnant or breast feeding, have known hiv infection, or are human anti-murine antibody (hama) positive.
Beskrivning

Pregnancy | Breast Feeding | HIV Infections | Human anti-mouse antibody Positive

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0019693
UMLS CUI [4,1]
C1291910
UMLS CUI [4,2]
C1514241
other criteria will be evaluated at the screening visit.
Beskrivning

criteria Other

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C0205394
Tillbaka till toppen

Similar models

Eligibility Lymphoma, Non-Hodgkin NCT00240565

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Lymphoma, Follicular persistent Evidence | Lymphoma, Follicular Progressive Evidence | Ann Arbor lymphoma staging system | Marginal Zone B-Cell Lymphoma Evidence
Item
patients must have evidence of persistent or progressive follicular grade, 1, 2 or 3 or marginal zone b-cell non-hodgkin's lymphoma.
boolean
C0024301 (UMLS CUI [1,1])
C0205322 (UMLS CUI [1,2])
C3887511 (UMLS CUI [1,3])
C0024301 (UMLS CUI [2,1])
C0205329 (UMLS CUI [2,2])
C3887511 (UMLS CUI [2,3])
C0432516 (UMLS CUI [3])
C1367654 (UMLS CUI [4,1])
C3887511 (UMLS CUI [4,2])
systemic therapy Course Quantity Lymphoma | rituximab | Disease Progression | Systemic Chemotherapy
Item
must have received at least two prior courses of systemic treatment including at least one treatment of rituximab (lymphoma must not have progressed during their most recent systemic chemotherapy treatment).
boolean
C1515119 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0024299 (UMLS CUI [1,4])
C0393022 (UMLS CUI [2])
C0242656 (UMLS CUI [3])
C1883256 (UMLS CUI [4])
Lymphoma CD20 Antigen Expression Evidence | Renal function | Liver function
Item
must have evidence that their lymphoma expresses cd20 antigen and have adequate renal and hepatic function.
boolean
C0024299 (UMLS CUI [1,1])
C0054946 (UMLS CUI [1,2])
C0017262 (UMLS CUI [1,3])
C3887511 (UMLS CUI [1,4])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Chemotherapy | Therapeutic radiology procedure | Immunosuppressive Agents | Cytokine therapy
Item
received chemotherapy, radiation therapy, immunosuppressants or cytokine treatment within 4 weeks prior to study entry.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0021081 (UMLS CUI [3])
C0199974 (UMLS CUI [4])
Hydronephrosis Obstructive
Item
have active obstructive hydronephrosis.
boolean
C0020295 (UMLS CUI [1,1])
C0549186 (UMLS CUI [1,2])
Transplantation of autologous hematopoietic stem cell | Allogeneic Stem Cell Transplantation
Item
had prior autologous hematopoietic stem cell transplant or any allogenic stem cell transplant.
boolean
C1831743 (UMLS CUI [1])
C2242529 (UMLS CUI [2])
Communicable Disease Requirement Intravenous antibiotic therapy
Item
have active infection requiring iv antibiotics.
boolean
C0009450 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0559680 (UMLS CUI [1,3])
Metastatic malignant neoplasm to brain | Metastatic Malignant Neoplasm to the Leptomeninges
Item
have brain or leptomeningeal metastasis.
boolean
C0220650 (UMLS CUI [1])
C1704231 (UMLS CUI [2])
Allergic Reaction Iodine | Radioimmunotherapy | Antineoplastic Agents Approved | Antineoplastic Agents Investigational
Item
had previous allergic reaction to iodine, previously received radioimmunotherapy or are currently receiving approved or experimental anti-cancer drugs.
boolean
C1527304 (UMLS CUI [1,1])
C0021968 (UMLS CUI [1,2])
C0085101 (UMLS CUI [2])
C0003392 (UMLS CUI [3,1])
C0205540 (UMLS CUI [3,2])
C0003392 (UMLS CUI [4,1])
C1517586 (UMLS CUI [4,2])
Pregnancy | Breast Feeding | HIV Infections | Human anti-mouse antibody Positive
Item
patients who are pregnant or breast feeding, have known hiv infection, or are human anti-murine antibody (hama) positive.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
C1291910 (UMLS CUI [4,1])
C1514241 (UMLS CUI [4,2])
criteria Other
Item
other criteria will be evaluated at the screening visit.
boolean
C0243161 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial